Senate Passes Mandate For Retailers’ Compliance With Combat Meth
This article was originally published in The Tan Sheet
Executive Summary
The Senate again sent a bill to the House requiring retailers selling pseudoephedrine-containing OTC products to train employees to comply with the Combat Methamphetamine Act
You may also be interested in...
Senate Meth Fight Pits Rx-Only Pseudoephedrine Against E-Tracking Option
The debate over how best to keep methamphetamine precursors from diversion to illicit drug labs is coming to a head as lawmakers stake out positions and legislation to restrict nonprescription access to pseudoephedrine waits in the wings
Singulair Switch Among Merck's OTC Possibilities
Merck may seek an OTC switch of its best-selling Singulair prescription medication, most likely asking for a nonprescription indication for allergic rhinitis
House bill tightens Combat Meth Act
Rep. Bart Gordon, D-Tenn., introduces the Combat Methamphetamine Enhancement Act of 2009, H.R. 2923, June 17. The legislation strengthens enforcement of the Combat Methamphetamine Act of 2006, which requires behind-the-counter sales of OTC products containing meth precursors pseudoephedrine and ephedrine, for consumers to show identification at points of sale and for retailers to log sales. It is a companion bill to legislation the Senate passed June 8 (1"The Tan Sheet" June 15, 2009). Both bills require retailers selling the products to self-certify -- using Drug Enforcement Administration guidelines -- that they have trained staff on Combat Meth Act compliance and for distributors to sell only to retailers registered with DEA. NACDS applauds: The National Association of Chain Drug Stores says it supports the legislation in a letter July 7 to Gordon. "These provisions will help prevent the diversion of ... products for illegitimate purposes, while still allowing consumers with legitimate needs to access" the drugs, NACDS President and CEO Steven Anderson said